English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51503574    在线人数 :  965
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"jia horng kao"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 651-675 / 1180 (共48页)
<< < 22 23 24 25 26 27 28 29 30 31 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-09-04T05:16:39Z Modelling NAFLD disease burden in four Asian regions—2019-2030 Estes C.; Chan H.L.Y.; Chien R.N.; Chuang W.-L.; Fung J.; Goh G.B.-B.; Hu T.H.; Huang J.-F.; Jang B.K.; Jun D.W.; JIA-HORNG KAO; Lee J.-W.; Lin H.-C.; Razavi-Shearer K.; Seto W.-K.; Wong G.L.H.; Wong V.W.S.; Razavi H.
臺大學術典藏 2021-09-04T05:16:38Z Highlights JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:38Z Highlights JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:38Z Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals Liu C.-H.; Lee M.-H.; Lin J.-W.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:37Z The clinical manifestations and management of COVID-19-related liver injury Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:37Z HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis Tseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:37Z Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:36Z 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO; Chuang W.-L.
臺大學術典藏 2021-09-04T05:16:36Z Hepatitis B: Immunization and Impact on Natural History and Cancer Incidence Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:35Z Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply Estes C.; Chan H.L.Y.; Chien R.N.; Chuang W.-L.; Fung J.; Goh G.B.-B.; Hu T.H.; Huang J.-F.; Jang B.K.; Jun D.W.; JIA-HORNG KAO; Lee J.-W.; Lin H.-C.; Razavi-Shearer K.; Seto W.-K.; Wong G.L.H.; Wong V.W.S.; Razavi H.
臺大學術典藏 2021-09-04T05:16:35Z Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing Yang Y.-C.; Chen Y.-H.; JIA-HORNG KAO; Ching C.; Liu I.-J.; Wang C.-C.; Tsai C.-H.; Wu F.-Y.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Yang H.-C.
臺大學術典藏 2021-09-04T05:16:35Z Highlights JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:34Z 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO; Chuang W.-L.
臺大學術典藏 2021-09-04T05:16:34Z Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations Gregory C.; Rino G.; Richard G.; Ghazinyan H.; Dokmeci K.; Tatsuo K.; JIA-HORNG KAO; George L.; Laurentius L.; Ismail M.; Masao O.; Diana P.; Teerha P.; Sarin S.K.; Manoj S.; Jose S.; Simone S.; Tawesak T.; Jafri W.; Lai W.; Mo Y.J.; Osamu Y.; Lau G.; Sharma M.; APASL Covid-19 Task Force
臺大學術典藏 2021-09-04T05:16:33Z Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:33Z Hepatitis B reactivation: diagnosis and management Huang S.-C.; Yang H.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:33Z Highlights JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:33Z Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏 2021-09-04T05:16:32Z Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943–2020) Yang H.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:31Z Hepatitis C virus genotypes 1–3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytes Hsu C.-S.; Liu W.-L.; Li Q.; Lowey B.; Hertz L.; Chao Y.-C.; Liang T.J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:31Z Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH) Huang C.-F.; Lai H.-C.; Chen C.-Y.; Tseng K.-C.; Kuo H.-T.; Hung C.-H.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Yu M.-L.
臺大學術典藏 2021-09-04T05:16:31Z HIGHLIGHTS JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:30Z Highlights JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:30Z Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients Yeo Y.H.; Tseng T.-C.; Hosaka T.; Cunningham C.; Fung J.Y.Y.; Ho H.J.; Kwak M.-S.; Trinh H.N.; Ungtrakul T.; Yu M.-L.; Kobayashi M.; Le A.K.; Henry L.; Li J.; Zhang J.; Sriprayoon T.; Jeong D.; Tanwandee T.; Gane E.; Cheung R.C.; Wu C.-Y.; Lok A.S.; Lee H.-S.; Suzuki F.; Yuen M.-F.; JIA-HORNG KAO; Yang H.-I.; Nguyen M.H.
臺大學術典藏 2021-09-04T05:16:30Z Progress towards elimination goals for viral hepatitis Cox A.L.; El-Sayed M.H.; JIA-HORNG KAO; Lazarus J.V.; Lemoine M.; Lok A.S.; Zoulim F.

显示项目 651-675 / 1180 (共48页)
<< < 22 23 24 25 26 27 28 29 30 31 > >>
每页显示[10|25|50]项目